Alto Neuroscience, Inc. (ANRO)

USD 3.64

(-3.96%)

Total Assets Summary of Alto Neuroscience, Inc.

  • Alto Neuroscience, Inc.'s latest annual total assets in 2023 was 86.62 Million USD , up 70.35% from previous year.
  • Alto Neuroscience, Inc.'s latest quarterly total assets in 2024 Q2 was 197.36 Million USD , down -5.98% from previous quarter.
  • Alto Neuroscience, Inc. reported annual total assets of 50.85 Million USD in 2022, up 76.61% from previous year.
  • Alto Neuroscience, Inc. reported annual total assets of 28.79 Million USD in 2021, down 0.0% from previous year.
  • Alto Neuroscience, Inc. reported quarterly total assets of 209.92 Million USD for 2024 Q1, up 142.33% from previous quarter.
  • Alto Neuroscience, Inc. reported quarterly total assets of 86.62 Million USD for 2023 Q4, up 62.72% from previous quarter.

Annual Total Assets Chart of Alto Neuroscience, Inc. (2023 - 2021)

Historical Annual Total Assets of Alto Neuroscience, Inc. (2023 - 2021)

Year Total Assets Total Assets Growth
2023 86.62 Million USD 70.35%
2022 50.85 Million USD 76.61%
2021 28.79 Million USD 0.0%

Peer Total Assets Comparison of Alto Neuroscience, Inc.

Name Total Assets Total Assets Difference
ADC Therapeutics SA 354.78 Million USD 75.583%
Annovis Bio, Inc. 10.2 Million USD -748.607%
Biohaven Pharmaceutical Holding Company Ltd. 513.21 Million USD 83.12%
Ginkgo Bioworks Holdings, Inc. 1.66 Billion USD 94.798%
Nuvation Bio Inc. 621.48 Million USD 86.061%
Nuvation Bio Inc. 621.48 Million USD 86.061%
Arcus Biosciences, Inc. 1.09 Billion USD 92.089%
Theriva Biologics, Inc. 60.21 Million USD -43.874%
Zymeworks Inc. 580.88 Million USD 85.087%